Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 4,943 | 4,598 | 4,136 | 1,089 | 0 |
| Cost of Goods | 3,236 | 3,497 | 2,733 | 546 | N/A |
| Gross Profit | 1,707 | 1,101 | 1,403 | 544 | N/A |
| Operating Expenses | 9,861 | 9,732 | 10,514 | 18,354 | 9,938 |
| Operating Income | -7,918 | -8,134 | -8,379 | -17,264 | -9,938 |
| Interest Expense | 372 | 0 | 0 | 0 | 360 |
| Other Income | 127 | 466 | 444 | -1,336 | 96 |
| Pre-tax Income | -8,162 | -7,669 | -7,935 | -18,600 | -10,203 |
| Income Tax | N/A | 7 | 13 | N/A | N/A |
| Net Income Continuous | -8,162 | -7,676 | -7,948 | -18,600 | -10,203 |
| Net Income | $-8,162 | $-7,676 | $-7,948 | $-18,600 | $-10,203 |
| EPS Basic Total Ops | -8.36 | -20.14 | -65.00 | -663.40 | -759.20 |
| EPS Basic Continuous Ops | -8.36 | -20.15 | -64.93 | -663.11 | -759.18 |
| EPS Diluted Total Ops | -8.36 | -20.14 | -65.00 | -663.40 | -759.20 |
| EPS Diluted Continuous Ops | -8.36 | -20.15 | -64.93 | -663.11 | -759.18 |
| EPS Diluted Before Non-Recurring Items | -8.36 | -20.20 | -65.00 | -663.40 | -760.00 |
| EBITDA(a) | $-7,705 | $-7,915 | $-8,177 | $-17,079 | $-9,817 |